A higher adherence to perindopril-based anti-hypertensive therapy is associated with a reduced risk of cardiovascular outcomes and all-cause mortality in real clinical practice in Italy

Back

ESC Professional Premium Access

A higher adherence to perindopril-based anti-hypertensive therapy is associated with a reduced risk of cardiovascular outcomes and all-cause mortality in real clinical practice in Italy

Session: Hypertension management: drugs

Topic: Pharmacotherapy

Speaker: Doctor S. Masi (Pisa, IT)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Stefano Masi

University of Pisa, Pisa (Italy)

5 presentations

0 follower

7 more presentations in this session

Systolic plood pressure response to ASi BI 690517 with and without empagliflozin in CKD

Speaker: Professor P. Rossing (Herlev, DK)

Adherence to anti-hypertensive therapy with perindopril-based single-pill versus free-pill combinations: a 10-year real-world analysis in Italy

Speaker: Associate Professor A. Vintila (Bucharest, RO)

The expanding role of semaglutide in cardiovascular disease and its the effect on blood pressure

Speaker: Doctor C. Kennedy (Dublin, IE)

Real-world analysis exploring the association between anti-hypertensive therapy with perindopril-based single-pill combinations (SPC) and cardiovascular outcomes and all-cause mortality in Italy

Speaker: Associate Professor J. Wolf (Gdansk, PL) Doctor S. Masi (Pisa, IT)

Injectable angiotensinogen inhibition therapy for hypertension: a systematic review and meta-analysis

Speaker: Doctor A. Yadav (New Delhi, IN)

Access the full session

Hypertension management: drugs

Speakers: Doctor S. Masi, Professor P. Rossing, Associate Professor A. Vintila, Doctor C. Kennedy, Associate Professor J. Wolf...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources